Clinical Trial Update: Predictive Value of Dynamic Contrast Enhancement MRI on a Cerebral Tumor Response to Gamma Knife Treatment

View source ↗

Summary

This trial evaluates whether dynamic contrast-enhanced MRI can predict cerebral tumor response to Gamma Knife radiosurgery in patients with cerebral metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Metastases

Snippet

Sponsor: Martin Lepage | Conditions: Cerebral Metastases | Status: COMPLETED